Skip to main content

Table 2 Adverse event (AE) incidence in ASAQ groups

From: Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa

Sign or Symptom

Adverse Event (AE)

Number of patients with AE

Total number of patients *

Incidence

Anorexia

789

2164

36%

Cough

509

1747

29%

Diarrhoea

526

2483

21%

Abdominal

280

1368

20%

Weakness

539

2749

20%

Vomiting

479

2937

16%

Skin symptom

118

759

16%

Pruritus

193

1636

12%

Headache

164

1739

9%

Myalgia

23

324

7%

Nausea

116

2104

6%

Dizziness

19

2150

1%

Jaundice

4

759

1%

Tinnitus

1

828

0%

  1. * The total number of patients was different since different signs or symptoms were screened across the studies.
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us